Next Article in Journal
Dengue Virus Serotype 2 Intrahost Diversity in Patients with Different Clinical Outcomes
Next Article in Special Issue
Novel SARS-CoV-2 Variants in Italy: The Role of Veterinary Public Health Institutes
Previous Article in Journal
Radioligand Assay-Based Detection of Antibodies against SARS-CoV-2 in Hospital Workers Treating Patients with Severe COVID-19 in Japan
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Erasing the Invisible Line to Empower the Pandemic Response

1
Department of Veterinary Medicine, University of Bari Aldo Moro, 70010 Valenzano, Italy
2
Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise ‘G. Caporale’, 64100 Teramo, Italy
3
One Health Center of Excellence, University of Florida, Gainesville, FL 32611, USA
*
Author to whom correspondence should be addressed.
Viruses 2021, 13(2), 348; https://doi.org/10.3390/v13020348
Submission received: 4 February 2021 / Revised: 20 February 2021 / Accepted: 22 February 2021 / Published: 23 February 2021
(This article belongs to the Special Issue Animal Viruses: State-of-the-Art Research in Italy)

Abstract

:
A challenging debate has arisen on the role of veterinary expertise in facing the SARS-CoV-2 pandemic. It seems totally unreasonable that in most countries, veterinary diagnostic and tracing forces were not deployed at the start to perform strategic tasks, which could have mitigated the outcome of this dramatic health emergency. Erasing the invisible line between human and veterinary virology will empower the response to future pandemics.

The 2020 pandemic has highlighted many fragilities of the systems in which we operate and rely on as human beings. One of the crucial areas which has most suffered within the health domain is that of activating pandemic reaction systems which include developing and/or applying novel diagnostics, collecting, managing, processing, and reporting for hundreds of thousands of unprogrammed samples with an imposed turn-around time that may well leave many errors behind, as understaffing and under resourcing become a main driving force.
In most countries, veterinary services have extensive experience in diagnosing and managing transboundary animal diseases, most of which are viral. Most viral pathogens which affect humans are the result of a spillover event from other animals [1]. These include HIV, Ebola, Zika but the most fearful due to their pandemic capacity are influenza A viruses (IAVs) and coronaviruses (CoVs). This evidence should lead us to reflect on Rudolf Virchow’s words in 1858: “Between animal and human medicine, there is no dividing line-nor should there be”. Actually, this line is visible to some humans and is reflected in policy, but is invisible to other animals or to the virus itself. Both virus groups in fact recognise animal reservoirs, mainly represented by birds and bats for IAVs and CoVs, respectively, but they are able to easily cross multiple species barriers jumping to humans directly or through intermediate hosts [2,3]. A large part of the scientific knowledge about the molecular mechanisms underlying the cross-species jumping of these viruses and their spillover to humans has been obtained by an outstanding community of veterinary virologists working in multidisciplinary teams.
It seems totally unreasonable that this invisible line has become a powerful dividing entity. The veterinary services and laboratory force could have been from day one an enormous support to the contact tracing (official veterinarians trace animals and their products all the time) and in sample reception, identification, storing, testing, processing, and reporting in ISO 17025-certified environments. In some countries, this external support has been activated and has been crucial, especially during the second wave [4,5,6].
There is one main aspect that needs to be resolved and this is the handling of human subjects for specimen collection and vaccine administration. It seems that similar to nurses, pharmacists, and dentists, also veterinarians may serve this purpose as they are already trained to swab and inject kittens, canary birds and million-dollar horses—and could include this extra activity in their educational curriculum. In addition, veterinarians manage a multitude of vaccination programs using −70 °C and liquid nitrogen-stored vaccines, such as Marek’s disease vaccine which is administered in billions of doses annually.
Last but not least, SARS-CoV-2 has the proven potential of spilling over into naïve animal species and thus of igniting a panzootic [7]. Such an occurrence could carry even more catastrophic consequences and cannot be ruled out. A multitude of domestic and wild animals have been proven to be susceptible to SARS-CoV-2 infection [8]. Cats and mink are infected after close contact with human patients who are positive for COVID-19 [9,10,11], and they are able to transmit SARS-CoV-2 to contact animals and even humans [8,11]. The spillback from mink to humans is of particular concern also due to the emergence of antigenic variants not fully neutralized by antibodies raised against previously circulating strains [11]. The emergence of multiple new variants is already occurring in humans [12] and must be monitored in animals through extensive sequencing, data sharing and open collaboration efforts.
Pandemics occur on a regular basis and we strive to prevent their emergence and to contain them at early stages. Most times we manage to keep these diseases under control but sometimes we fail. Being equipped with more efficient and multidisciplinary response teams cannot exclude that we will fail in containing the pandemics in the future. However, it can give us a better chance in preventing (or significantly slowing down) the worldwide spread of the next pandemic virus.

Author Contributions

Conceptualization, writing—original draft preparation, writing—review and editing, all authors. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chan, J.F.; To, K.K.; Tse, H.; Jin, D.Y.; Yuen, K.Y. Interspecies transmission and emergence of novel viruses: Lessons from bats and birds. Trends Microbiol. 2013, 21, 544–555. [Google Scholar] [CrossRef] [PubMed]
  2. Decaro, N.; Lorusso, A. Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses. Vet. Microbiol. 2020, 244, 108693. [Google Scholar] [CrossRef] [PubMed]
  3. Romero-Tejeda, A.; Capua, I. Virus-specific factors associated with zoonotic and pandemic potential. Influenza Other Respir. Viruses 2013, 7, 4–14. [Google Scholar] [CrossRef] [PubMed]
  4. Lorusso, A.; Calistri, P.; Mercante, M.T.; Monaco, F.; Portanti, O.; Marcacci, M.; Cammà, C.; Rinaldi, A.; Mangone, I.; Di Pasquale, A.; et al. A “One-Health” approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy. One Health 2020, 10, 100135. [Google Scholar] [CrossRef] [PubMed]
  5. De Melo, R.T.; Rossi, D.A.; Monteiro, G.P.; Fernandez, H. Veterinarians and One Health in the Fight against Zoonoses Such as COVID-19. Front. Vet. Sci. 2020, 7, 576262. [Google Scholar] [CrossRef] [PubMed]
  6. Yoo, H.S.; Yoo, D. COVID-19 and veterinarians for one health, zoonotic- and reverse-zoonotic transmissions. J. Vet. Sci. 2020, 21, e51. [Google Scholar] [CrossRef] [PubMed]
  7. Gollakner, R.; Capua, I. Is COVID-19 the first pandemic that evolves into a panzootic? Vet. Ital. 2020, 56, 7–8. [Google Scholar] [CrossRef] [PubMed]
  8. Hedman, H.D.; Krawczyk, E.; Helmy, Y.A.; Zhang, L.; Varga, C. Host Diversity and Potential Transmission Pathways of SARS-CoV-2 at the Human-Animal Interface. Pathogens 2021, 10, 180. [Google Scholar] [CrossRef] [PubMed]
  9. Hosie, M.J.; Hofmann-Lehmann, R.; Hartmann, K.; Egberink, H.; Truyen, U.; Addie, D.D.; Belák, S.; Boucraut-Baralon, C.; Frymus, T.; Lloret, A.; et al. Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic. Viruses 2021, 13, 185. [Google Scholar] [CrossRef] [PubMed]
  10. Patterson, E.I.; Elia, G.; Grassi, A.; Giordano, A.; Desario, C.; Medardo, M.; Smith, S.L.; Anderson, E.R.; Prince, T.; Patterson, G.T.; et al. Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy. Nat. Commun. 2020, 11, 6231. [Google Scholar] [CrossRef] [PubMed]
  11. Larsen, H.D.; Fonager, J.; Lomholt, F.K.; Dalby, T.; Benedetti, G.; Kristensen, B.; Urth, T.R.; Rasmussen, M.; Lassaunière, R.; Rasmussen, T.B.; et al. Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020. Euro Surveill. 2021, 26, 2100009. [Google Scholar] [CrossRef] [PubMed]
  12. Rubin, E.J.; Baden, L.R.; Farrar, J.J.; Morrissey, S. Audio Interview: Viral Variants and Covid-19. N. Engl. J. Med. 2021, 384, e38. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Decaro, N.; Lorusso, A.; Capua, I. Erasing the Invisible Line to Empower the Pandemic Response. Viruses 2021, 13, 348. https://doi.org/10.3390/v13020348

AMA Style

Decaro N, Lorusso A, Capua I. Erasing the Invisible Line to Empower the Pandemic Response. Viruses. 2021; 13(2):348. https://doi.org/10.3390/v13020348

Chicago/Turabian Style

Decaro, Nicola, Alessio Lorusso, and Ilaria Capua. 2021. "Erasing the Invisible Line to Empower the Pandemic Response" Viruses 13, no. 2: 348. https://doi.org/10.3390/v13020348

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop